Amanda Dawson, MD
Plastic and Reconstructive Surgery · Omaha, NENPI 1871932731
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,909 of the $4,584 with a category attached, or 85.3%. 20 manufacturers reported payments, led by AbbVie at 55.8% of the total. Reporting peaked in 2021 at $1,431 and has fallen 77.4% since, to $323 in 2025.
Across 66 payments — averaging $69.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- TELA Bio, Inc.$590
- Wardlow Enterprises$385
- Baxter Healthcare$334
- Sientra, Inc.$181
- Musculoskeletal Transplant Foundation Inc.$133
- plus $401 from 14 others
What the payments were for
- Travel & lodging$2906%
- Food & beverage$3,90985%
- Education$3858%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 41 | $2,559 |
| TELA Bio, Inc. | 4 | $590 |
| Wardlow Enterprises | 1 | $385 |
| Baxter Healthcare | 2 | $334 |
| Sientra, Inc. | 1 | $181 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $133 |
| Davol Inc. | 2 | $80 |
| Checkpoint Surgical, Inc | 1 | $74 |
| Vertex | 2 | $48 |
| KCI USA, Inc. | 1 | $26 |
| Roche Diagnostics Corporation | 1 | $25 |
| Integra Lifesciences Corporation | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| Kerecis Limited | 1 | $20 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Innovation Technologies Inc | 1 | $15 |
| Mallinckrodt Enterprises LLC | 1 | $15 |
| Portola Pharmaceuticals, LLC | 1 | $13 |
| Smith+Nephew | 1 | $13 |
| Intercept Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few plastic and reconstructive surgery providers in Nebraskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $226 |
| Cephalexin | 12 | $88 |
| Ondansetron Hcl | 27 | $81 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Omaha
- Andrew HollinsOmaha$12K
- Nagi AyoubOmaha$4K
- Jordan BloughOmaha$3K
- Brian BiggerstaffOmaha$2K
- Rita SticeOmaha$596
- Jeffrey PoppOmaha$231
- Ashley JohnsonOmaha$174
- Mitchell HenryLincoln$2K
- Cassidy MitchellLincoln$2K
- Joel AtchisonKearney$735
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.